Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension

European Heart Journal

Volumn 36, Issue 10, 2015, Pages 623-631

  Shah, Amil M ^a   Campbell, Patricia ^a   Rocha, Gabriela Querejeta ^a   Peacock, Andrew ^b   Barst, Robyn J ^c   Quinn, Debbie ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Scottish Pulmonary Vascular Unit   (United Kingdom)

^c College of Physicians and Surg ^*  (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Echocardiography; Pulmonary heart disease; Pulmonary hypertension; Trials

Indexed keywords

IMATINIB; PLACEBO; ANTIHYPERTENSIVE AGENT;

ADD ON THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; LEFT VENTRICULAR DIASTOLIC FUNCTION; LEFT VENTRICULAR SYSTOLIC FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PEAK SYSTOLIC VELOCITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RIGHT VENTRICULAR FRACTIONAL AREA CHANGE; RIGHT VENTRICULAR TEI INDEX; TISSUE DOPPLER IMAGING; TISSUE DOPPLER TRICUSPID ANNULAR PEAK SYSTOLIC VELOCITY; TREATMENT DURATION; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION; TRICUSPID VALVE REGURGITATION; ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECTS; ECHOGRAPHY; EXERCISE TOLERANCE; HEART STROKE VOLUME; HYPERTENSION, PULMONARY; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; MULTICENTER STUDY; OBSERVER VARIATION; PATHOPHYSIOLOGY; TRICUSPID VALVE INSUFFICIENCY; VASCULAR RESISTANCE;

ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY, LEFT VENTRICULAR; IMATINIB MESYLATE; MALE; MIDDLE AGED; OBSERVER VARIATION; STROKE VOLUME; TRICUSPID VALVE INSUFFICIENCY; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84924351120     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu035     Document Type: Article

References (33)

1. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-Term pulmonary arterial hypertension disease management (REVEAL). Circulation 2010;122:164-172
2. Kanemoto N. Natural history of pulmonary hemodynamics in primary pulmonary hypertension. Am Heart J 1987;114:407-413
3. D"Alonzo GE, Barst RJ, Ayres AM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT, Levy PS, Pietra GG, Reid LM, Reeves JT, Rich S, Vreim CE, Williams GW, Wu M. Survival in patients with primary pulmonary hypertension. Ann Intern Med 1991;115:343-349
4. Eysmann SB, Palevsky HI, Reichek N, Hackney K, Douglas PS. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989;80:353-360
5. Hinderliter AL, Willis PW, Barst RJ, Rich S, Rubin LJ, Badesch DB, Groves BM, McGoon MD, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, Jobsis MM, Blackburn SD, Crow JW, Long WA. Effects of long-Term infusion of prostacyclin (Epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 1997;95:1479-1486
6. Galie N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T, Espinola-Zavaleta N, Rocchi G, Manes A, Frantz R, Kurzyna M, Nagueh SF, Barst R, Channick R, Dujardin K, Kronenberg A, Leconte I, Rainisio M, Rubin L. Effects of the oral endothelin-receptor antagonist Bosentan on echocardiographic and Doppler measures in patients with pulmonary hypertension. J Am Coll Cardiol 2003;41:1380-1386
7. Seyfarth HJ, Pankau H, Hammerschmidt S, Schauer J, Wirtz H, Winkler J. Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy. Chest 2005;128:709-713
8. Hoeper MM, Barst RJ, Bourge RC, Feldman J, Frost AE, Galie N, Gomez-Sanchez MA, Grimminger F, Grunig E, Hassoun PM, Morrell NW, Peacock AJ, Satoh T, Simonneau G, Tapson VF, Torres F, Lawrence D, Quinn D, Ghofrani HA. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study. Circulation 2013; (epub 12 February 2013
9. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography"s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography"s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463
11. Abbas AE, Fortuin D, Schiler NB, Appleton CP, Moreno CA, Lester SJ. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 2003;41:1021-1027
12. Kouzu H, Nakatani S, Kyotani S, Kanzaki H, Nakanishi N, Kitakaze M. Noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. Am J Cardiol 2009;103: 872-876
13. Van de Veerdonk MC, Kind T, Marcus JT, Mauritz GJ, Heymans MW, Bogaard HJ, Boonstra A, Marques KM, Westerhof N, Vonk-Noordegraaf A. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011;58:2511-2519
14. Zornoff LAM, Skali H, Pfeffer MA, St John Sutton M, Rouleau JL, Lamas GA, Plappert T, Rouleau JR, Moye LA, Lewis SJ, Braunwald E, Solomon SD. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Coll Cardiol 2002;39, 1450-1455
15. Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, McMurray JJ, Velazquez E, Califf R, Pfeffer MA, Solomon SD. Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study). Am J Cardiol 2008;101: 607-612
16. Ghio S, Klersy C, Magrini G, D"Armini AM, Scelsi L, Raineri C, Pasotti M, Serio A, Campana C, Vigano M. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol 2010;140:272-278
17. Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Schwartz T, Koch G, Clayton LM, Jobsis MM, Crow JW, Long W. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002;39: 1214-1219
18. Brierre G, Blot-Souletie N, Degano B, Tetu L, Bongard V, Carrie D. New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension. Eur J Echocardiogr 2010;11:516-522
19. Hinderliter AL, Willis PW, Long W, Clarke WR, Ralph D, Caldwell EJ, William W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B, Koch G, Li S, Clayton LM, Jobsis MM, Crow JW. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. Am J Cardiol 1999;84:481-484
20. Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers. J Am Soc Echocardiogr 2009;22:776-792
21. Moustapha A, Lim M, Saikia S, Kaushik V, Kang SH, Barasch E. Interrogation of the tricuspid annulus by Doppler tissue imaging in patients with chronic pulmonary hypertension: implications for the assessment of right ventricular systolic and diastolic function. Cardiology 2001;95:101-104
22. Meluzin J, Spinarova L, Bakala J, Toman J, Krejci J, Hude P, Kara T, Soucek M. Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion: a new, rapid, and non-invasive method of evaluating right ventricular systolic function. Eur Heart J 2001;22:340-348
23. Wang J, Prakasa K, Bomma C, Tandri H, Dalal D, James C, Tichnell C, Corretti M, Bluemke D, Calkins H, Abraham TP. Comparison of novel echocardiographic parameters of right ventricular function with ejection fraction by cardiac magnetic resonance. J Am Soc Echocardiogr 2007;20:1058-1064
24. Gurudevan SV, Malouf PJ, Kahn AM, Auger WR, Waltman TJ, Madani M, DeMaria AN, Blanchard DG. Noninvasive assessment of pulmonary vascular resistance using Doppler tissue imaging of the tricuspid annulus. J Am Soc Echocardiogr 2007;20:1167-1171
25. Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, Chamera E, Corretti MC, Champion HC, Abraham TP, Girgis RE, Hassoun PM. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Resp Crit Care Med 2006;174:1034-1041
26. Giusca S, Dambrauskaite V, Scheurwegs C, D"hooge J, Claus P, Herbots L, Magro M, Rademakers F, Meyns B, Delcroix M, Voigt JU. Deformation imaging describes right ventricular function better then longitudinal displacement of the tricuspid ring. Heart 2010;96:281-288
27. Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD, Tajik AJ, Seward JB. Doppler echocardiographic index for assessment of global right ventricular function. J AmSoc Echocardiogr 1996;9:838-847
28. Yei TC, Dujardin KS, Tei C, Mahoney DW, McGoon MD, Seward JB. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol 1998;81: 1157-1161
29. Ross J. Acute displacement of the diastolic pressure-volume curve of the left ventricle: role of the pericardium and the right ventricle. Circulation 1979;59:32-37
30. Chang SM, Lin CC, Hsiao SH, Lee CY, Huang WC. Pulmonary hypertension and left heart function: insights from tissue Doppler imaging and myocardial performance index. Echocardiography 2007;24:366-373
31. Yilmaz R, Gencer M, Ceylan E, Demirbag R. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance. J Am Soc Echocardiogr 2005;18:873-881
32. Gomberg-Maitland M, Dufton C, Oudiz RJ, Benza RL. Compelling evidence of longterm outcomes in pulmonary arterial hypertension?. A clinical perspective. J Am Coll Cardiol 2011;57:1053-1061
33. Oudiz RJ, Galie N, Olschewski H, Torres F, Frost A, Ghofrani HA, Badesch DB, McGoon MD, McLaughlin VV, Roecker EB, Harrison BC, Despain D, Dufton C, Rubin LJ. Long-Term ambrisentan therapy for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:1971-1981